Area of research
Internal Medicine · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes, Blood Coagulation and Thrombosis Mechanisms, and Hemophilia Treatment and Research.
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.
Recent Advances in Thrombosis and Hemostasis-Part XIII.
Rates and risk factors for major adverse cardiovascular and cerebrovascular events after stroke due to intracerebral hemorrhage: Systematic review and study-level meta-analysis.
Duration of primary/secondary treatment to prevent recurrent venous thromboembolism: a systematic review and meta-analysis
Duration of primary/secondary treatment to prevent recurrent venous thromboembolism: a systematic review and meta-analysis.
Excess risk of bleeding in patients with venous thromboembolism on direct oral anticoagulants during initial and extended treatment versus population controls.
Influence of Direct Oral Anticoagulant Levels and Thrombin Generation on Postoperative Bleeding [SONAR]: A Nested Case-Control Study.
Time Trends and Excess Mortality Compared to Population Controls after a First-Time Pulmonary Embolism or Deep Vein Thrombosis.
Time Trends in Cause-specific Mortality in Patients with Pulmonary Embolism Aged 50 Years and Older.
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19.
The Basic Principles of Pathophysiology of Venous Thrombosis.
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper.
Outcomes of Patients with a Mechanical Heart Valve and Poor Anticoagulation Control on Warfarin.
Prothrombin complex concentrate for emergency surgery in patients on oral Xa-inhibitors.
Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trial.
The Basic Principles of Pathophysiology of Venous Thrombosis
"2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19": reply.
CHC and surgery: when is stopping safe?
Coordination of oral anticoagulant care at hospital discharge (COACHeD): pilot randomised controlled trial.
Erratum: Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus Paper.
Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score
Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and Haemostasis
Outcomes of Patients with a Mechanical Heart Valve and Poor Anticoagulation Control on Warfarin
Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and Haemostasis.
Antithrombotic management of patients with deep vein thrombosis and venous stents: an international registry
Potential for a Virtual Care Model in the Perioperative Management of Anticoagulant Therapy: A 5-Year Retrospective Clinic Review.
Anticoagulant Management and Outcomes in Nontraumatic Intracranial Hemorrhage Complicated by Venous Thromboembolism: A Retrospective Chart Review.